Company Overview

Network Immunology Inc. is a privately held biotechnology company developing novel immuno-therapies based on the immune network framework.

Network Immunology's lead preclinical stage product, TheraNet™, is an entirely novel antibody for the treatment of the human immunodeficiency virus (HIV).


Dr. Sybille Muller and Dr. Heinz Kohler join team at Network Immunology

Two experienced immunologists in the field of immune network science, Dr. Sybille Muller and Dr. Heinz Kohler, have joined Network Immunology. Dr. Muller has been appointed to the Board of Direct..

Network Immunology Announces MAB3™

Network Immunology, a preclinical stage biotech company focused on novel treatments to prevent and treat automimmune conditions and cancer, announces a new monoclonal antibody-based technology. Ne..

Network Immunology Inc. Reports Filing of New Intellectual Property

Network Immunology, a preclinical stage biotech company focused on novel treatments to prevent and treat automimmune conditions and cancer, files patent for HIV and organ transplantation technolog..

Corporate Updates

Captcha Image